PF-07304814 + Placebo
Phase 1Completed 0 watching 0 views this week💤 Quiet
32
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Viral Disease
Conditions
Viral Disease
Trial Timeline
Sep 9, 2020 → Jun 7, 2021
NCT ID
NCT04535167About PF-07304814 + Placebo
PF-07304814 + Placebo is a phase 1 stage product being developed by Pfizer for Viral Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT04535167. Target conditions include Viral Disease.
Hype Score Breakdown
Clinical
10
Activity
5
Company
9
Novelty
3
Community
2
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04627532 | Phase 1 | Completed |
| NCT04535167 | Phase 1 | Completed |
Competing Products
17 competing products in Viral Disease